Sandoz opens biosimilar drug development center in Ljubljana

Swiss pharmaceutical giant Sandoz, through its Slovenian subsidiary Lek, has officially opened a new development center for biosimilar drugs in Ljubljana. The facility, located near Verovškova Street, represents a significant investment and is poised to establish Ljubljana as a key global hub for Sandoz's research and development efforts in this specialized field.

Gregor Makuc, CEO of Lek and President of Sandoz Slovenia, stated that the center is crucial for expanding access to affordable treatments. He emphasized that this opening marks the beginning of a comprehensive chain in Slovenia, integrating development with production for biosimilar drugs. This move positions Ljubljana as Sandoz's leading development center for biosimilars.

“

This facility we are opening is inspiring not only because of its structure, high technology, or process improvements. It is important because of the knowledge, because of the development capabilities, and above all, because of the people.

"This facility we are opening is inspiring not only because of its structure, high technology, or process improvements. It is important because of the knowledge, because of the development capabilities, and above all, because of the people," Makuc remarked during the opening. The center, spanning 10,000 square meters, was constructed in just over two years and completed within its budget. The investment totals $99 million, slightly exceeding the initial estimate from two years ago.

President Nataša Pirc Musar of Slovenia hailed the opening as a testament to the country's knowledge, capabilities, and potential. She noted that Slovenia, despite its size, can significantly contribute to advancements shaping the future of Europe and the world through vision, expertise, and strong partnerships. The pharmaceutical and biotechnology sectors are increasingly vital to Slovenia's economy, driven by its strengths in human capital, knowledge, and a robust academic and research environment.

“

It is proof that even a small country with the right vision, top experts, and strong partnerships can significantly contribute to the development of areas that will decisively shape the future of Europe and the world.